Robert Tighe

Person

North Reading, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
CD137 antibodies and tumor antigen-targeting antibodies and uses th...
- Patent number 11,851,497
- Issue date Dec 26, 2023
- Compass Therapeutics LLC
- Robert V. Tighe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 11,752,207
- Issue date Sep 12, 2023
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD137 antibodies and PD-1 antagonists and uses thereof
- Patent number 11,718,679
- Issue date Aug 8, 2023
- Compass Therapeutics LLC
- Ugur Eskiocak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 10,716,851
- Issue date Jul 21, 2020
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 10,434,175
- Issue date Oct 8, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 10,350,292
- Issue date Jul 16, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 10,279,039
- Issue date May 7, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 10,279,040
- Issue date May 7, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonist antibodies that bind human CD137 and uses thereof
- Patent number 10,279,038
- Issue date May 7, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING CD70 SPECIFIC...
- Publication number 20240252641
- Publication date Aug 1, 2024
- TCR2 Therapeutics Inc.
- Robert Hofmeister
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20240181050
- Publication date Jun 6, 2024
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
- Publication number 20240117002
- Publication date Apr 11, 2024
- Robert TIGHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD137 ANTIBODIES AND PD-1 ANTAGONISTS AND USES THEREOF
- Publication number 20240002525
- Publication date Jan 4, 2024
- Compass Therapeutics LLC
- Ugur Eskiocak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR GAMMA DELTA TCR REPROGRAMMING USING FU...
- Publication number 20230069322
- Publication date Mar 2, 2023
- TCR2 Therapeutics Inc.
- Jian DING
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CANCER
- Publication number 20230065936
- Publication date Mar 2, 2023
- TCR2 Therapeutics Inc.
- Alfonso QUINTÁS-CARDAMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD137 ANTIBODIES AND PD-1 ANTAGONISTS AND USES THEREOF
- Publication number 20210221902
- Publication date Jul 22, 2021
- Compass Therapeutics LLC
- Ugur Eskiocak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20200306374
- Publication date Oct 1, 2020
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD137 ANTIBODIES AND TUMOR ANTIGEN-TARGETING ANTIBODIES AND USES TH...
- Publication number 20200308293
- Publication date Oct 1, 2020
- Compass Therapeutics LLC
- Robert V. Tighe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20200046833
- Publication date Feb 13, 2020
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20190269776
- Publication date Sep 5, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20190224315
- Publication date Jul 25, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20190125866
- Publication date May 2, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20190099488
- Publication date Apr 4, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20190060454
- Publication date Feb 28, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC IMMUNOMODULATORY ANTIGEN-BINDING CONSTRUCTS
- Publication number 20190031785
- Publication date Jan 31, 2019
- Compass Therapeutics LLC
- Thomas Joseph SCHUETZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
- Publication number 20190015508
- Publication date Jan 17, 2019
- Compass Therapeutics LLC
- Piotr Bobrowicz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC IMMUNOMODULATORY ANTIGEN-BINDING CONSTRUCTS
- Publication number 20180318417
- Publication date Nov 8, 2018
- Compass Therapeutics LLC
- Thomas Joseph SCHUETZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-IL-1R1 Inhibitors For Use in Cancer
- Publication number 20140308294
- Publication date Oct 16, 2014
- Merck Patent GmbH
- Anita Seshire
- G01 - MEASURING TESTING

Robert Tighe

Person

Patents Grantslast 30 patents

CD137 antibodies and tumor antigen-targeting antibodies and uses th...

Agonist antibodies that bind human CD137 and uses thereof

CD137 antibodies and PD-1 antagonists and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING CD70 SPECIFIC...

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

CD137 ANTIBODIES AND PD-1 ANTAGONISTS AND USES THEREOF

COMPOSITIONS AND METHODS FOR GAMMA DELTA TCR REPROGRAMMING USING FU...

COMPOSITIONS AND METHODS FOR TREATING CANCER

CD137 ANTIBODIES AND PD-1 ANTAGONISTS AND USES THEREOF

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

CD137 ANTIBODIES AND TUMOR ANTIGEN-TARGETING ANTIBODIES AND USES TH...

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

MULTISPECIFIC IMMUNOMODULATORY ANTIGEN-BINDING CONSTRUCTS

AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

MULTISPECIFIC IMMUNOMODULATORY ANTIGEN-BINDING CONSTRUCTS

Anti-IL-1R1 Inhibitors For Use in Cancer